Medical Devices · 10-year plan
[Result]
A 10-year innovation roadmap for a medical device leader
A category-leading device company wanted significant growth in current and new markets over a 10-year horizon.
Read the case →Problem we solve · Innovation, Portfolio & Customer Insight
“We fund R&D on technical promise. The market case comes later, if at all.”
When projects are funded on technical promise, the portfolio fills with ideas nobody will buy. A simple opportunity assessment and NPV view before R&D begins makes projects comparable and kills weak ideas early.
Cause 1
No commercial-friendly tools
Cause 2
No common scoring criteria
Cause 3
No governance cadence
Paraphrased and anonymized from recent conversations.
“We lack structured processes for evaluating ideas before R&D begins and want simple, repeatable tools.”
The approaches we use most often for this problem. Most clients start with one.
How we help
We give R&D and commercial teams a simple, repeatable way to assess ideas before R&D starts: a one-page overview, an NPV model and consistent scoring, shown in one portfolio view..
How it works →How we help
We set up the review rhythm, decision rights and data discipline that keep an innovation portfolio honest, including real customer experiments at each gate..
How it works →Market Edge frameworks used to diagnose and fix this problem.
Medical Devices · 10-year plan
[Result]
A category-leading device company wanted significant growth in current and new markets over a 10-year horizon.
Read the case →Articles by Market Edge consultants on mkt-edge.com.
No. The tools are Excel-based.
A cross-functional group, using the same criteria every time.
Innovation, Portfolio & Customer Insight
“Our gates check documents, not evidence.”
Read more →Innovation, Portfolio & Customer Insight
“Mature products take all our time. Lifecycle decisions keep getting postponed.”
Read more →Innovation, Portfolio & Customer Insight
“We bought the market report. It doesn't answer our question.”
Read more →Book a 20–30 minute sounding board conversation with a senior consultant who has sat in your seat. No cost, no commitment.